Implantica
Manufacturing · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Baarerstrasse 57, Zug, Zug, 6300, Switze...Phone Number
+41 415391908Website
www.implantica.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Implantica
Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB).Explore more
Implantica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Implantica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Implantica is spiking on competitors!
Implantica, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Implantica had a recent Job posting/layoffs
Product Launch: Get notified when Implantica launches new products
Funding: Get notified immidiatlly once Implantica has new funding data
Congratulate Masked Content for being promoted to Masked Content at Implantica
Check if Implantica has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Implantica recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Implantica as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Implantica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Implantica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Implantica.
Implantica Tech Stack
A closer look at the technologies used by Implantica
Implantica News & Media
Implantica presents the second quarter (Q2 2026) on August 21 at 15:00 CEST
VADUZ, Liechtenstein, Aug. 14, 2026 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the second quarter 2026 at 15:00 CEST on August 21. The interim report for the second quarter (Q2 2026) will be published at 8:00 a.m. CEST on the same day. The presentation...Bulletin from the Annual General Meeting of Implantica AG
VADUZ, Liechtenstein, June 10, 2026 /PRNewswire/ -- Today, June 10, 2026, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting resolved to adopt all of the board of directors' resolution proposals. A summary of the...Implantica announces launch of 20th RefluxStop® Center of Excellence in Spain, part of a world-renowned US hospital group
VADUZ, Liechtenstein, June 9, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers,...Implantica publishes Interim Report January - March 2026 (Q1)
VADUZ, Liechtenstein, May 22, 2026 /PRNewswire/ -- Substantially Advancing Clinical Outcomes & Economic Impact of RefluxStop® Significant events in the first quarter of 2026 Secured over EUR 1.2 million in new multi-year public tender approvals in Italy, further strengthening...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Implantica
Sign Up For FreeTo access detailed company insights
Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealt... Read More
